secwatch.observer — SEC 8-K summary
======================================

Issuer:     DNA X, Inc. (SONM)
CIK:        0001178697
Form:       8-K
Filed at:   2026-07-02T12:55:15+00:00
Accession:  0001493152-26-031675
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 5.03, 3.02, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DNA X enters securities purchase agreement for $8.1M private placement of Series B Preferred Stock
--------------------------------------------------------------------------------

- DNA X agreed to issue 1,346,531 shares of Series B Convertible Preferred Stock at $6.00 per share to DNA Holdings Venture, Inc. for aggregate $8.1M.
- The $8.1M consists of $5.0M in cash and cancellation of $3.1M convertible promissory note issued in May 2026.
- DNA Holdings is an entity associated with board member Scott Walker and holds >5% of DNA X common stock.
- The Series B Preferred Stock is non-voting and automatically converts to common stock upon stockholder approval.
- DNA X also entered into a registration rights agreement for resale of common shares issuable upon conversion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178697/000149315226031675/0001493152-26-031675-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178697/000149315226031675/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-031675

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer